Millennium Management
VYNE icon

Millennium Management’s VYNE Therapeutics VYNE Stock Holding History

Millennium Management’s Portfolio VYNE Stock Details VYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,990
Closed -$33.7K – 6605
2024
Q1 		$33.7K Sell
10,990
-6,283
-36% -$13.5K ﹤0.01% 5750
2023
Q4 		$40.2K Buy
+17,273
New +$53.8K ﹤0.01% 5518
2023
Q2 		– Sell
-27,312
Closed -$84K – 6741
2023
Q1 		$84K Buy
27,312
+200
+0.7% +$718 ﹤0.01% 5477
2022
Q4 		$73K Buy
27,112
+16,072
+146% +$64.2K ﹤0.01% 5678
2022
Q3 		$44K Buy
11,040
+1,906
+21% +$12.2K ﹤0.01% 6230
2022
Q2 		$64K Sell
9,134
-10,533
-54% -$88.4K ﹤0.01% 6097
2022
Q1 		$230K Sell
19,667
-4,304
-18% -$51.2K ﹤0.01% 5751
2021
Q4 		$440K Sell
23,971
-53
-0.2% -$1.14K ﹤0.01% 5172
2021
Q3 		$601K Sell
24,024
-13,710
-36% -$532K ﹤0.01% 5185
2021
Q2 		$2.38M Buy
37,734
+36,290
+2,513% +$2.87M ﹤0.01% 3754
2021
Q1 		$178K Buy
+1,444
New +$209K ﹤0.01% 5529
2020
Q4 		– Sell
-584
Closed -$70 – 5629
2020
Q3 		$70 Sell
584
-18,491
-97% -$2.16M ﹤0.01% 4271
2020
Q2 		$2.38M Buy
+19,075
New +$2.58M ﹤0.01% 2398
2018
Q3 		– Sell
-2,973
Closed -$1.74M – 4311
2018
Q2 		$1.74M Buy
+2,973
New +$2.31M ﹤0.01% 2494

Other funds holding VYNE

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Millennium Management's VYNE Position: Q2 2024 in Review

Millennium Management sold out of VYNE Therapeutics (VYNE) in Q2 2024, closing a stake of 10,990 shares — an estimated $33.7K sold.

Millennium Management first reported a position in VYNE in Q2 2018 and held it in 14 quarters. The position peaked at $2.38M in Q2 2021. 32 funds tracked by Wall St. Rank hold VYNE as of Q2 2024.

  • Millennium Management reported no remaining VYNE Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Millennium Management sold 10,990 VYNE Therapeutics shares in Q2 2024, an estimated $33.7K.
  • Millennium Management first reported a position in VYNE Therapeutics in Q2 2018 and held it in 14 quarters.
  • Millennium Management's VYNE Therapeutics position peaked at $2.38M in Q2 2021.
  • 32 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.